Technology
Waldencast plc(WALDW)
Live Price
Offline$0.054
-6.90% today
1Y Change
-9.09%
Window
Jun 23, 2025 → Jun 9, 2026
- Market Cap
- $100.00M
- Revenue Growth
- -0.7%
- EPS Growth
- -415.4%
- Dividend Yield
- 0.0%
Coverage: 242 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Waldencast plc (WALDW) is a Technology stock with a market cap of $100.00M and listed on NASDAQ. The stock last traded around $0.05 and down 9.1% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of -0.7%, EPS growth of -415.4%, a dividend yield of 0.0%. What stands out right now is revenue -0.7%, EPS -415.4%, free cash flow -37.3% with operating margin -22.7% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WALDW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-0.7% vs +11.9% peer median
Operating Margin
Below sector median
-22.7% vs +22.0% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -0.7% and EPS is at -415.4%, with operating margin around -22.7%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WALDW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WALDW Max Drawdown
-71.13%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for WALDW and SPY.
Company Overview
Waldencast plc
NASDAQ Capital Market
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
- Leadership
- Michel Brousset
- IPO Date
- May 19, 2021
- Employees
- 335
- Street Address
- 10 Bank Street
- Mailing
- White Plains, NY, 10606
- Region
- White Plains, NY, US
- Reporting Currency
- USD
- Investor Line
- 917 546 6828
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.4
- Price/Book
- 0.2
Growth
- Revenue
- -0.7%
- EPS
- -415.4%
- Free Cash Flow
- -37.3%
Profitability
- Gross Margin
- 45.5%
- Operating Margin
- -22.7%
- Net Margin
- -84.4%
- ROE
- -47.8%
- ROIC
- -7.8%
Balance Sheet
- Debt/Equity
- 0.32
- Current Ratio
- 1.70
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.